Spruce Street Capital »

Helix Acquisition Corp Iii shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Helix Acquisition Corp Iii (HLXC) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Helix Acquisition Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Iii held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Iii by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.3M 500k 10.64

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Helix Acquisition Corp Iii

Cormorant Asset Management
Affinity Asset Advisors
RA Capital Management
Nantahala Capital Management
Silverarc Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Braidwell
Toronto-Dominion Bank
Millennium Management
Decagon Asset Management
OZ Management
J. Goldman & Co
Spruce Street Capital
Commodore Capital

View all funds holding Helix Acquisition Corp Iii